Home » Market News » DirectorsTalk Highlights » International Drug Discovery Science and Technology conference
Avacta Group Plc

International Drug Discovery Science and Technology conference

CSO Dr Amrik Basran to present on Affimer bispecifics at upcoming International Drug Discovery Science and Technology Conference in Kyoto, Japan July 25th-27th.

“Affimer Therapeutics: A novel human protein scaffold for the generation of bi-specific molecules” will be presented at 08:35am Saturday July 27th in the Therapeutic Proteins and Peptides session in the New Biotherapy Discovery stream.  

Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.